GLIPITA-M

This brand name is authorized in Nigeria.

Active ingredients

The drug GLIPITA-M contains one active pharmaceutical ingredient (API):

1	Sitagliptin UNII TS63EW8X6F - SITAGLIPTIN PHOSPHATE
	Sitagliptin is a member of a class of oral anti-hyperglycaemic agents called dipeptidyl peptidase 4 (DPP-4) inhibitors. The improvement in glycaemic control observed with this medicinal product may be mediated by enhancing the levels of active incretin hormones.
	Read more about Sitagliptin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-7628	Tablet	Glipita-M 50/1000 Tablets TAB 50 mg 3 x 10's (in PVC-Alu blisters)	Film Coated Tablet Capsule-shaped, orange film coated tablet plain on one side 76 RNW-PP-292284 GLIPITA-M 50/1000 TABLETS SITAGLIPTIN PHOSPHATE MONOHYDRATE BP EQUIVALENT TO SITAGLIPTIN 50MG, METFORMIN HYDROCHLORIDE BP 1000MG SITAGLIPTIN PHOSPHATE MONOHYDRATE BP EQUIVALENT TO SITAGLIPTIN 50MG, METFORMIN HYDROCHLORIDE BP 1000MG, MICROCRYSTALLINE CELLULOSE, SODIUM LAURYL SULPHATE, POVIDONE, SODIUM STEARYL FUMARATE, ISOPROPYL ALCOHOL, TITANIUM DIOXIDE, MAGNESIUM STEARATE, OPADRY II (ORANGE), LECITHIN, FD & C YELLOW, SUNSET YELLOW, IRON OXIDEYELLOW, ALLURA RED, CARNAUBA WAX, PURIFIED WATER B4-7628 Drugs Imported Products 310 Prescription Only Medicine (POM) 10/27/2022 STADARD GENERICE LTD, ABOR CLOSE, OFF FOLA AGORO ST, YABA LAGOS LAGOS 12799144 stdgenerics@yahoo.com Beximco Pharmaceutical Ltd, 126, Kathaldia, Auchpara, Tongi, Gazipur, Bangladesh, Bangladesh	27/07/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A10BD07	Metformin and sitagliptin	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BD Combinations of oral blood glucose lowering drugs
Discover more medicines within A10BD07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-7628